Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: Implications for acquired immunodeficiency syndrome-associated vasculopathy

Blood

Volumn 93, Issue 12, 1999, Pages 4232-4241

  Ascherl, G ^b   Hohenadl, C ^b   Schatz, O ^b   Shumay, E ^b   Bogner, J ^b   Eckhart, L ^b   Tschachler, E ^b   Monini, P ^b   Ensoli, B ^b   Sturzl M ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; VASCULOTROPIN; ZALCITABINE; ZIDOVUDINE;

ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; T LYMPHOCYTE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ALTERNATIVE SPLICING; BLOTTING, WESTERN; CELL LINE; CULTURE MEDIA, CONDITIONED; CYTOKINES; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION; HIV-1; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; RNA, MESSENGER; SARCOMA, KAPOSI; T-LYMPHOCYTES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033564358     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Holland GN, Repose JS, Pettit TH, Gottlieb MS, Yee KD, Foos RY: Acquired immune deficiency syndrome. Ocular manifestations. Ophthalmology 90:859, 1983
2. Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY: Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology 92:472, 1985
3. Rhodes RH: Evidence of serum-protein leakage across the blood-brain barrier in the acquired immunodeficiency syndrome. J Neuropathol Exp Neurol 50:171, 1991
4. Petito CK, Cash KS: Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: Immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 32:658, 1992
5. Nottet HS, Persidsky Y, Sasseville VG, Nukuna AN, Bock P, Zhai QH, Sharer LR, McComb RD, Swindells S, Soderland C, Gendelman HE: Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol 156:1284, 1996
6. Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M: A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 158:3499, 1997
7. Zietz C, Hotz B, Stürzl M, Rauch E, Penning R, Löhrs U: Aortic endothelium in HIV-1 infection: Chronic injury, activation, and increased leukocyte adherence. Am J Pathol 149:1887, 1996
8. Stürzl M, Brandstetter H, Roth WK: Kaposi's sarcoma: A review of gene expression and ultrastructure of KS spindle cells in vivo. AIDS Res Hum Retroviruses 8:1753, 1992
9. Ensoli B, Stürzl M: Kaposi's sarcoma: A result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev 9:63, 1998
10. Barillari G, Buonaguro L, Fiorelli V, Hoffman J, Michaels F, Gallo RC, Ensoli B: Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol 149:3727, 1992
11. Honda M, Kitamura K, Mizutani Y, Oishi M, Arai M, Okura T, Igarahi K, Yasukawa K, Hirano T, Kishimoto T, Mitsuyasu R, Chermann JC, Tokunaga T: Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases. J Immunol 145:4059, 1990
12. Hober D, Haque A, Wattre P, Beaucaire G, Mouton Y, Capron A: Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNF-alpha is related to a higher cytotoxic activity. Clin Exp Immunol 78:329, 1989
13. Lähdevirta J, Maury CP, Teppo AM, Repo H: Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 85:289, 1988
14. Lepe-Zuniga JL, Mansell PW, Hersh EM: Idiopathic production of interleukin-1 in acquired immune deficiency syndrome. J Clin Microbiol 25:1695, 1987
15. Sinicco A, Biglino A, Sciandra M, Forno B, Pollono AM, Raiteri R, Gioannini P: Cytokine network and acute primary HIV-1 infection. AIDS 7:1167, 1993
16. Poli G, KinterA, Justement JS, Kehrl JH, Bressler P, Stanley S, Fauci AS: Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA 87:782, 1990
17. + T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: An immune response to human herpesvirus-8 infection? Blood 91:956, 1998
18. Sirianni MC, Vincenzi L, Fiorelli V, Topino S, Scala E, Uccini S, Angeloni A, Faggioni A, Cerimele D, Cottoni F, Aiuti F, Ensoli B: γ-Interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: Correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages. Blood 91:968, 1998
19. Stürzl M, Brandstetter H, Zietz C, Eisenburg B, Raivich G, Gearing DP, Brockmeyer NH, Hofschneider PH: Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: A combined in vitro and in vivo analysis. Oncogene 10:2007, 1995
20. Fan ST, Hsia K, Edgington TS: Upregulation of human immunodeficiency virus-1 in chronically infected monocytic cell line by both contact with endothelial cells and cytokines. Blood 84:1567, 1994
21. Lafeuillade A, Alessi MC, Poizot-Martin I, Boyer-Neumann C, Zandotti C, Quilichini R, Aubert L, Tamalet C, Juhan-Vague I, Gastaut JA: Endothelial cell dysfunction in HIV infection. J AIDS 5:127, 1992
22. Teitel JM, Shore A, Read SE, Schiavone A: Immune function of vascular endothelial cells is impaired by HIV. J Infect Dis 160:551, 1989
23. Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B: Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 95:1723, 1995
24. Cornali E, Zietz C, Benelli R, Weninger W, Masiello L, Breier G, Tschachler E, Albini A, Stürzl M: Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol 149:1851, 1996
25. Samaniego F, Markham PD, Gendelman R, Gallo RC, Ensoli B: Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. J Immunol 158:1887, 1997
26. Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B: Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Am J Pathol 152:1433, 1998
27. Buonaguro L, Barillari G, Chang HK, Bohan CA, Kao V, Morgan R, Gallo RC, Ensoli B: Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol 66:7159, 1992
28. Scala G, Ruocco MR, Ambrosino C, Mallardo M, Giordano V, Baldassarre F, Dragonetti E, Quinto I, Venuta S: The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J Exp Med 179:961, 1994
29. Dhawan S, Pun RK, Kumar A, Duplan H, Massen JM, Aggarwal BB: Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood 90:1535, 1997
30. Hofman FM, Wright AD, Dohadwala MM, Wong-Staal F, Walker SM: Exogenous tat protein activates human endothelial cells. Blood 82:2774, 1993
31. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M, Cafaro A, Chang HK, Brady JN, Gallo RC: Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371:674, 1994
32. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851, 1989
33. Gospodarowicz D, Abraham JA, Schilling J: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 86:7311, 1989
34. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306, 1989
35. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309, 1989
36. Ballaun C, Weninger W, Uthman A, Weich H, Tschachler E: Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol 104:7, 1995
37. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947, 1991
38. Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW: The vascular endothelial growth factor family of polypeptides. J Cell Biochem 47:211, 1991
39. Poltorak Z, Cohen T, Sivan R, Kandelis Y, Spira G, Vlodavsky I, Keshet E, Neufeld G: VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 272:7151, 1997
40. Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K, Eriksson U: Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 93:2576, 1996
41. Yamada Y, Nezu J, Shimane M, Hirata Y: Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics 42:483, 1997
42. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the FIt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:1751, 1996
43. Ferrara N, Chen H, Davis-Smyth T, Gerber HP, Nguyen TN, Peers D, Chisholm V, Hillan KJ, Schwall RH: Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 4:336, 1998
44. Beck L Jr, D'Amore PA: Vascular development: Cellular and molecular regulation. FASEB J 11:365, 1997
45. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D: Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172:1535, 1990
46. Benjamin LE, Keshet E: Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 94:8761, 1997
47. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983, 1983
48. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE, Klagsbrun M: Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis. Cancer Res 55:4140, 1995
49. Bunn PA Jr, Foss FM: T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: History and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL). J Cell Biochem Suppl 24:12, 1996
50. Gazdar AF, Carney DN, Bunn PA, Russell EK, Jaffe ES, Schlechter GP, Guccion JG: Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood 55:409, 1980
51. Shaw GM, Hahn BH, Arya SK, Groopman JE, Gallo RC, Wong-Staal F: Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science 226:1165, 1984
52. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267:26031, 1992
53. Breier G, Albrecht U, Sterrer S, Risau W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114:521, 1992
54. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345:84, 1990
55. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC: Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67:277, 1993
56. Iijima K, Yoshikawa N, Nakamura H: Activation-induced expression of vascular permeability factor by human peripheral T cells: A non-radioisotopic semiquantitative reverse transcription-polymerase chain reaction assay. J Immunol Methods 196:199, 1996
57. Bussolino F, Mantovani A, Persico G: Molecular mechanisms of blood vessel formation. Trends Biochem Sci 22:251, 1997
58. Masood R, Cai J, Zheng T, Smith DL, Naidu Y, Gill PS: Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci USA 94:979, 1997
59. Yang J, Xu Y, Zhu C, Hagan MK, Lawley T, Offermann MK: Regulation of adhesion molecule expression in Kaposi's sarcoma cells. J Immunol 152:361, 1994